Clinical trial
The Relationship Between Neuropsychological Testing and MRI, PET and Blood Biomarkers in Neurodegenerative Disease (COBRE - Project 1): AIM 2
NCT03702816 is registered in ClinicalTrials.gov with Aaron Ritter, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Relationship Between Neuropsychological Testing and MRI, PET and Blood Biomarkers in Neurodegenerative Disease (COBRE - Project 1): AIM 2
- Lead sponsor
- Aaron Ritter, MD
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- December 13, 2018
- Completion date
- September 29, 2019
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.